Interesting article in news com regarding a cancer treatment for melanoma. They are talking about an injectable that appears to be in place of chemo, and is injected every two weeks. Results in 40% reduction in many tumors as oposed to 17% for chemo. Doesnt really go into the mechanism but interesting when compared with the possible myc inhibitor results. All comes back to the injectable thing i guess, assuming this drug is just injected intravenously and not actually targetted at a tumor.
They seem to be quite excited about this drug at its outrageous cost, and yet all it appears to do is reduce tumor size and then hold tumor stable preventing re growth. Obviously massive, but not that great compared to omomyc results when targetted at a tumor. I guess its a shame we appear to have gone away from targetting tumors as this is a great way to compare results when reffering to tumor reduction.
Its a long path but maybe once they fiinnaaallllyyyy come up with their own primary myc inhibitor and actually start some trialling we may open up this field?
Its now 6 months from when a myc inhibitor was supposed to be named in november, and pretty much no "non generic" word on where we are actually at since? Hopefully in an ideal world they will finally reveal they now have a contender, and as a bonus they reveal a raft of amazing results that were achieved while validating the candidate. After all im sure they will need to test the contenders against actual cancer cells so they should have some impressive "better than omomyc" results when and if they ever get there. I guess that does give some insight into why it is taking so long with the validation required.
PYC Price at posting:
1.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)